View in EDS HTML Full Text PDF Full Text

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.

Saved in:
Bibliographic Details
Title: A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
Authors: Dart CR; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Mukherjee N; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA., Amato CM; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Goulding A; College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766, USA., MacBeth M; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Van Gulick R; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Couts KL; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Lambert JR; Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8104, Aurora, CO 80045, USA., Norris DA; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO 80220, USA., Robinson WA; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Shellman YG; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Gates Center for Regenerative Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Jul 30; Vol. 14 (8). Date of Electronic Publication: 2021 Jul 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34451846
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dart+CR%22">Dart CR</searchLink>; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Mukherjee+N%22">Mukherjee N</searchLink>; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Amato+CM%22">Amato CM</searchLink>; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Goulding+A%22">Goulding A</searchLink>; College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766, USA.<br /><searchLink fieldCode="AU" term="%22MacBeth+M%22">MacBeth M</searchLink>; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Van+Gulick+R%22">Van Gulick R</searchLink>; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Couts+KL%22">Couts KL</searchLink>; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Lambert+JR%22">Lambert JR</searchLink>; Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8104, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Norris+DA%22">Norris DA</searchLink>; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO 80220, USA.<br /><searchLink fieldCode="AU" term="%22Robinson+WA%22">Robinson WA</searchLink>; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Shellman+YG%22">Shellman YG</searchLink>; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Gates Center for Regenerative Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2021 Jul 30; Vol. 14 (8). <i>Date of Electronic Publication: </i>2021 Jul 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34451846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph14080749
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dart CR
      – PersonEntity:
          Name:
            NameFull: Mukherjee N
      – PersonEntity:
          Name:
            NameFull: Amato CM
      – PersonEntity:
          Name:
            NameFull: Goulding A
      – PersonEntity:
          Name:
            NameFull: MacBeth M
      – PersonEntity:
          Name:
            NameFull: Van Gulick R
      – PersonEntity:
          Name:
            NameFull: Couts KL
      – PersonEntity:
          Name:
            NameFull: Lambert JR
      – PersonEntity:
          Name:
            NameFull: Norris DA
      – PersonEntity:
          Name:
            NameFull: Robinson WA
      – PersonEntity:
          Name:
            NameFull: Shellman YG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2021 Jul 30
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1424-8247
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Pharmaceuticals (Basel, Switzerland)
              Type: main
ResultId 1